Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $571.54 | 14 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Horizon Therapeutics plc | $240.37 | 2 | $0 (2023) |
| Amgen Inc. | $124.99 | 1 | $0 (2024) |
| Calliditas Therapeutics US Inc. | $62.74 | 3 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $34.89 | 2 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $27.17 | 2 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $26.63 | 1 | $0 (2023) |
| Lilly USA, LLC | $25.62 | 1 | $0 (2023) |
| Almatica Pharma LLC | $15.32 | 1 | $0 (2024) |
| Biogen, Inc. | $13.81 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $167.39 | 4 | Amgen Inc. ($124.99) |
| 2023 | $288.77 | 9 | Horizon Therapeutics plc ($124.99) |
| 2022 | $115.38 | 1 | Horizon Therapeutics plc ($115.38) |
All Payment Transactions
14 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/04/2024 | Biogen, Inc. | ZURZUVAE (Drug) | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: Neurology | ||||||
| 03/21/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Inflammation/Rare Disease | ||||||
| 02/20/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: INTERNAL MEDICINE | ||||||
| 01/24/2024 | Almatica Pharma LLC | TERIPARATIDE (Drug) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: OSTEOPOROSIS | ||||||
| 10/18/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.62 | General |
| Category: Diabetes | ||||||
| 09/28/2023 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $26.63 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/07/2023 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: NEPHROLOGY | ||||||
| 08/29/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: INTERNAL MEDICINE | ||||||
| 07/26/2023 | Calliditas Therapeutics US Inc. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: Nephrology | ||||||
| 07/26/2023 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: NEPHROLOGY | ||||||
| 07/13/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: KRYSTEXXA | ||||||
| 05/24/2023 | Calliditas Therapeutics US Inc. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: Nephrology | ||||||
| 03/29/2023 | Calliditas Therapeutics US Inc. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: Nephrology | ||||||
| 07/14/2022 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $115.38 | General |
| Category: KRYSTEXXA | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 219 | 64,578 | $435,982 | $165,991 |
| 2022 | 2 | 27 | 49 | $6,886 | $1,646 |
| 2021 | 5 | 70 | 70 | $44,860 | $5,671 |
| 2020 | 2 | 35 | 35 | $26,325 | $2,229 |
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J1306 | Injection, inclisiran, 1 mg | Office | 2023 | 24 | 11,644 | $280,490 | $109,382 | 39.0% |
| J1439 | Injection, ferric carboxymaltose, 1 mg | Office | 2023 | 38 | 52,500 | $119,292 | $46,238 | 38.8% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 86 | 232 | $31,502 | $8,792 | 27.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 55 | 122 | $3,459 | $1,071 | 31.0% |
| J3489 | Injection, zoledronic acid, 1 mg | Office | 2023 | 16 | 80 | $1,239 | $507.28 | 41.0% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 15 | 37 | $6,411 | $1,537 | 24.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 12 | 12 | $475.84 | $108.60 | 22.8% |
| 23472 | Prosthetic repair of shoulder joint, total shoulder | Facility | 2021 | 14 | 14 | $19,250 | $2,153 | 11.2% |
| 29827 | Repair of shoulder rotator cuff using an endoscope | Facility | 2021 | 15 | 15 | $10,125 | $1,616 | 16.0% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 13 | 13 | $1,690 | $862.68 | 51.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 13 | 13 | $1,170 | $771.81 | 66.0% |
| 29826 | Shaving of shoulder bone using an endoscope | Facility | 2021 | 15 | 15 | $12,625 | $267.68 | 2.1% |
| 29827 | Repair of shoulder rotator cuff using an endoscope | Facility | 2020 | 17 | 17 | $11,475 | $1,898 | 16.5% |
| 29826 | Shaving of shoulder bone using an endoscope | Facility | 2020 | 18 | 18 | $14,850 | $330.95 | 2.2% |
About Jonathon Gibson
Jonathon Gibson is a Orthopaedic Surgery healthcare provider based in Foley, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/23/2019. The National Provider Identifier (NPI) number assigned to this provider is 1205489804.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jonathon Gibson has received a total of $571.54 in payments from pharmaceutical and medical device companies, with $167.39 received in 2024. These payments were reported across 14 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($571.54).
As a Medicare-enrolled provider, Gibson has provided services to 351 Medicare beneficiaries, totaling 64,732 services with total Medicare billing of $175,536. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Practice Information
- Specialty Orthopaedic Surgery
- Other Specialties Family
- Location Foley, AL
- Active Since 07/23/2019
- Last Updated 07/14/2022
- Taxonomy Code 207X00000X
- Entity Type Individual
- NPI Number 1205489804
Products in Payments
- KRYSTEXXA (Biological) $365.36
- TARPEYO (Drug) $62.74
- JYNARQUE (Drug) $34.89
- ENTYVIO (Biological) $27.17
- LOKELMA (Drug) $26.63
- JARDIANCE (Drug) $25.62
- TERIPARATIDE (Drug) $15.32
- ZURZUVAE (Drug) $13.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Orthopaedic Surgery Doctors in Foley
Timothy Frerichs, Md, MD
Orthopaedic Surgery — Payments: $13,246
Dr. Todd Edmiston, Md, MD
Orthopaedic Surgery — Payments: $12,232
Dr. William Roberts, Md, MD
Orthopaedic Surgery — Payments: $355.37
Dr. Lester Littell, M.d, M.D
Orthopaedic Surgery — Payments: $66.98
Raymond Fletcher, Md, MD
Orthopaedic Surgery